About Ryvis Pharma Private Limited
Data last updated:
Ryvis Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 26 November 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2008PTC185273. Its GSTIN is 27AACCV8951E1Z3 (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Vyser Pharma Private Limited. It is led by directors including Gopal Rajan Sethi and Seema Sethi.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 91 Springboard B1/H3 Mohan Co – Operative, Mathura Rd Industrial Area Block B New Delhi Delhi – 110044, Delhi, India – 110044.
As per the financials filed for FY 2024, the company reported a revenue of ₹13.51 Cr, a growth of 44% compared to the previous year. For the same year it recorded a net profit of ₹1.62 Lakh (net margin 0.1%) and EBITDA of ₹6.85 Lakh (EBITDA margin 0.5%). Revenue has grown at a compounded annual rate (CAGR) of 16% over three years and 45% over five years.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ryvispharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address91 Springboard B1/H3 Mohan Co – Operative, Mathura Rd Industrial Area Block B New Delhi Delhi – 110044, Delhi, India – 110044
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Ryvis Pharma Private Limited
The main business activity of Ryvis Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Ryvis Pharma Private Limited FY 2024 filings available
Ryvis Pharma Private Limited reported revenue of ₹13.51 Cr (up 44% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Ryvis Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 45% over five years, including 44% growth in the latest year. EBITDA rose 117% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Ryvis Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹6.85 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.62 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Ryvis Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Ryvis Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Ryvis Pharma Private Limited
Ryvis Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Profile Axis Private Limited | ₹13.59 Cr (FY 2025) | •••• | •••• | 8.0% | •••• | Bangalore, Karnataka, India |
| Brawn Biotech Limited Listed | ₹13.56 Cr (FY 2025) | •••• | •••• | -18.0% | •••• | Delhi, India |
| Immucare Bioscience Trading Private Limited | ₹13.53 Cr (FY 2024) | •••• | •••• | •••• | Bhopal, Madhya Pradesh, India | |
| Ardent Life Sciences Private Limited | ₹13.53 Cr (FY 2024) | •••• | •••• | 29.0% | •••• | Pune, Maharashtra, India |
| Sri Devi Distributors Private Limited | ₹13.52 Cr (FY 2024) | •••• | •••• | 30.0% | •••• | Chennai, Tamil Nadu, India |
| Ryvis Pharma Private Limited this company | ₹13.51 Cr (FY 2024) | •••• | •••• | 44.0% | •••• | New Delhi, Delhi, India |
| Vivan Acidchem Private Limited | ₹13.5 Cr (FY 2022) | •••• | •••• | 6.0% | •••• | Indore, Madhya Pradesh, India |
| Avrohn Pharma (I) Limited | ₹13.49 Cr (FY 2025) | •••• | •••• | 69.0% | •••• | Delhi, India |
| Namh Meditech Private Limited | ₹13.44 Cr (FY 2025) | •••• | •••• | 199.0% | •••• | Ahmedabad, Gujarat, India |
| Bansal Drugs Private Limited | ₹13.41 Cr (FY 2024) | •••• | •••• | 37.0% | •••• | Uttar Pradesh, India |
| Shivalya Mart Private Limited | ₹13.38 Cr (FY 2024) | •••• | •••• | 143.0% | •••• | Kolkata, West Bengal, India |
Peers are the five companies nearest above and the five nearest below Ryvis Pharma by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Ryvis Pharma Private Limited
Ryvis Pharma Private Limited is audited by PAREKH SHARMA & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| PAREKH SHARMA & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Ryvis Pharma Private Limited
Ryvis Pharma has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gopal Rajan Sethi | Director | 26 Nov 2008 | 17 Years 10 Months | Current |
| Seema Sethi | Director | 26 Nov 2008 | 17 Years 10 Months | Current |
| Upasana Bhatia | Director | 30 Dec 2016 | 9 Years 9 Months | Current |
| Karuna Bhatia | Director | 28 Oct 2019 | 6 Years 11 Months | Current |
Ownership and Shareholding of Ryvis Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Ryvis Pharma Private Limited
Ryvis Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Ryvis Pharma Private Limited
Employment history and EPFO contributions of people linked to Ryvis Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Ryvis Pharma Private Limited
Ryvis Pharma Private Limited has 4 board changes on record since 2008: 4 appointments. The latest: Karuna Bhatia was appointed as Director on 28 Oct 2019.
Credit Ratings, Litigation & Regulatory Alerts for Ryvis Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Ryvis Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Ryvis Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Ryvis Pharma Private Limited
Ryvis Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCV8951E1Z3 | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Ryvis Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ryvis Pharma Private Limited
Ryvis Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 26 November 2008 (18+ years old) and is registered under CIN U24232DL2008PTC185273.
Ryvis Pharma reported revenue of ₹13.51 Cr for FY 2024 (up 44% YoY).
Ryvis Pharma has 4 current directors:
- Gopal Rajan Sethi - Director
- Seema Sethi - Director
- Upasana Bhatia - Director
- Karuna Bhatia - Director
Ryvis Pharma reported a net profit of ₹1.62 Lakh (net margin 0.1%) and EBITDA of ₹6.85 Lakh (EBITDA margin 0.5%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Ryvis Pharma is 16% over three years and 45% over five years. In the latest year (FY 2024) revenue rose 44%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Ryvis Pharma is 27AACCV8951E1Z3, registered in Maharashtra.
The CIN (Corporate Identification Number) of Ryvis Pharma is U24232DL2008PTC185273. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ryvis Pharma was incorporated on 26 November 2008, making it 18+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Ryvis Pharma by revenue are Profile Axis Private Limited, Brawn Biotech Limited, Immucare Bioscience Trading Private Limited, Ardent Life Sciences Private Limited, Sri Devi Distributors Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Karuna Bhatia was appointed as Director on 28 Oct 2019. Upasana Bhatia was appointed as Director on 30 Dec 2016. Gopal Rajan Sethi was appointed as Director on 26 Nov 2008. Ryvis Pharma has 4 board changes on record in total.
Ryvis Pharma can be reached through the website ryvispharma.com. Its registered office is in New Delhi, Delhi, India.